Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-23-002311
Filing Date
2023-03-20
Accepted
2023-03-20 09:13:21
Documents
2
Group Members
PATRICK G. G. DEARREADE E. GRIFFITHTETRAGON FINANCIAL GROUP LTDTETRAGON FINANCIAL MANAGEMENT L.P.

Document Format Files

Seq Description Document Type Size
1 TETRAGON FINANCIAL MANAGEMENT LP p23-1110sc13ga.htm SC 13G 86860
2 JOINT FILING AGREEMENT p23-1110exhibit99.htm EX-99.1 7577
  Complete submission text file 0000902664-23-002311.txt   96217
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90550 | Film No.: 23745058
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 359-7300
Tetragon Financial Management LP (Filed by) CIK: 0001758892 (see all company filings)

EIN.: 203311552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G